Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 29654-29655 [06-4772]
Download as PDF
<![CDATA[
29654
Federal Register / Vol. 71, No. 99 / Tuesday, May 23, 2006 / Notices
records movement, capturing movement
intensity and duration and associating it
with clock-time. This new
accelerometer will be used in the
Hispanic Community Health Study and
will allow examination of levels as well
as patterns of activity. Physical activity
was measured with accelerometers in
the nationally representative 2003–2006
National Health and Nutrition
Examination Survey (NHANES) (OMB#:
0920–0237, October 15, 2004, Vol 69,
pp. 61253–61254). NHANES provides
estimates for Mexican-American, but
not other Hispanic subgroups. Between
the time of the NHANES and the
Hispanic Community Health Study,
there has been a change in the
technology of the accelerometer used in
NHANES. To allow comparison of the
physical activity data that will be
collected from the four Hispanic
subgroups in the Hispanic Community
Study to the data collected with the
previous technology used in NHANES,
a cross-validation study is needed. The
proposed study, the ActiGraph
Accelerometer Validation Study, will
serve this purpose. It is a crossvalidation study comparing the two
ActiGraph accelerometer models under
different circumstances of walking or
Number of
participants
Data Collection Task
rmajette on PROD1PC67 with NOTICES
Screener .....................................................................
Height and weight ......................................................
Accelerometer fitting ..................................................
Walking track .............................................................
There are no Capital Costs to report.
There are no Operating or Maintenance
Costs to report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility,
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used, (3) Ways to enhance
the quality, utility and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, New Executive
Office Building, Room 10235,
Washington, DC 20503, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Dr.
Richard Troiano, CDR, U.S. Public
VerDate Aug<31>2005
15:14 May 22, 2006
Jkt 208001
Frequency
of response
144
120
120
120
Average
time per
response
1
1
1
1
Health Service, Risk Factor Monitoring
and Methods Branch, Applied Research
Program, Division of Cancer Control and
Population Sciences, National Cancer
Institute, EPN 4005, 6130 Executive
Blvd, MSC 7344, Bethesda, MD 20892–
7344, or call non-toll-free number 301435–6822, or FAX your request to (301)
435–3710, or E-mail your request,
including your address, to:
troianor@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
Dated: May 16, 2006.
Rachelle Ragland-Greene,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. E6–7857 Filed 5–22–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the tenth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
8:30 a.m. to approximately 5 p.m. on
Monday, June 26, 2006 and 8:30 a.m. to
approximately 5 p.m. on Tuesday, June
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
jogging in differing age groups and for
both genders. Frequency of response:
One-time study. Affected Public:
Individuals. Type of Respondents:
Healthy adults between the ages of 18–
74 years. The annual reporting burden
is as follows: Estimated Number of
Respondents: 144; Estimated Number of
Responses per Respondent: 1.14;
Average Burden Hours Per Response:
0.66; and Estimated Total Annual
Burden Hours Requested: 62. The
annualized cost to respondents is
estimated at: $1116.
Annual hour
burden
Hourly wage
rate
12
10
20
20
62
$18.00
18.00
18.00
18.00
....................
0.25
0.25
0.5
0.5
0.66
Cost to
respond
$216
180
360
360
1116
27, 2006, at the National Institutes of
Health, Building 31, C Wing, Conference
Room 6, 31 Center Drive, Bethesda, MD
20892. The meeting will be open to the
public with attendance limited to space
available. The meeting also will be
Webcast.
The first day of the meeting will
include a review of the Committee’s
draft report and recommendations on
pharmacogenomics, and a briefing on
FDA’s Critical Path Initiative. The
Committee will also hear from the
Centers for Medicare & Medicaid
Services ont he status of a proposal to
add a genetics specialty to the
regulations implementing the Clinical
Laboratory Improvement Act
Amendments. In addition, the
Committee will discuss the status of its
solicitation of public comments on the
Committee’s draft report ‘‘Policy Issues
Associated with Undertaking a Large
U.S. Population Cohort Project on
Genes, Environment, and Disease’’
(posted at https://www4.od.nih.gov/oba/
sacghs/public_comments.htm).
Issues to be discussed on the second
day will include several presentations
intended to provide the Committee with
a better understanding of the impact of
gene patents and licensing practices on
access to genetic tests and services as
well as deliberations about the
Committee’s next steps on this issue.
The Committee will also be updated
about the status of Federal genetic nondiscrimination legislation and the work
of the two interagency work groups
monitoring claims made by companies
advertising genetic tests on the Internet
E:\FR\FM\23MYN1.SGM
23MYN1
Federal Register / Vol. 71, No. 99 / Tuesday, May 23, 2006 / Notices
and evaluating the public health impact
of DTC marketing of genetic tests.
Time will be provided each day for
public comments. The Committee
would welcome hearing from anyone
wishing to provide public comment on
any issue related to genetics, health and
society. Individuals who would like to
provide public comment should notify
the SACGHS Executive Secretary, Ms.
Sarah Carr, by telephone at 301–496–
9838 or E-mail at sc112c@nih.gov. The
SACGHS office is located at 6705
Rockledge Drive, Suite 750, Bethesda,
MD 20892. Anyone planning to attend
the meeting who is in need of special
assistance, such as sign language
interpretation or other reasonable
accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a,
section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
technologies and, as warranted, to
provide advice on these issues. The
draft meeting agenda and other
information about SACGHS, including
information about access to the
Webcast, will be available at the
following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
Dated: May 15, 2006.
Anna Snouffer,
Acting Director, NIH Office of Federal
Advisory Committee Policy.
[FR Doc. 06–4772 Filed 5–22–06; 8:45 am]
National Institutes of Health
rmajette on PROD1PC67 with NOTICES
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
Jkt 208001
Dated: May 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4788 Filed 5–22–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Center on Minority Health and
Health Disparities; Notice of Closed
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
15:14 May 22, 2006
Name of Committee: National Cancer
Institute Special Emphasis Panel, Review of
R25T Application.
Date: June 19, 2006.
Time: 11:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Ilda M. McKenna, PhD.,
Scientific Review Administrator, Research
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard Room
8111, Bethesda, MD 20892. 301–496–7481,
mckennai@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
National Institutes of Health
BILLING CODE 4140–01–M
VerDate Aug<31>2005
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center on
Minority Health and Health Disparities
Special Emphasis Panel, Loan Repayment
Program Applications—HD & ECR—Panel D.
Date: June 9, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
29655
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Suite 800, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Lorrita Watson, PhD,
National Center on Minority Health and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892–5465. (301) 402–1366.
watsonl@ncmhd.nih.gov.
Dated: May 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4775 Filed 5–22–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: June 8–9, 2006.
Closed: June 8, 2006, 8:30 a.m. to 11:30
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Delegate
Room D, Bethesda, MD 20892.
Open: June 8, 2006, 11:30 a.m. to 5 p.m.
Agenda: Following opening remarks by the
Director, NEI, there will be presentations by
the staff of the Institute and discussion
concerning Institute programs.
E:\FR\FM\23MYN1.SGM
23MYN1
]]>Agencies
[Federal Register Volume 71, Number 99 (Tuesday, May 23, 2006)]
[Notices]
[Pages 29654-29655]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-4772]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary's Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92-463, notice is hereby given of the tenth
meeting of the Secretary's Advisory Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health Service. The meeting will be held
from 8:30 a.m. to approximately 5 p.m. on Monday, June 26, 2006 and
8:30 a.m. to approximately 5 p.m. on Tuesday, June 27, 2006, at the
National Institutes of Health, Building 31, C Wing, Conference Room 6,
31 Center Drive, Bethesda, MD 20892. The meeting will be open to the
public with attendance limited to space available. The meeting also
will be Webcast.
The first day of the meeting will include a review of the
Committee's draft report and recommendations on pharmacogenomics, and a
briefing on FDA's Critical Path Initiative. The Committee will also
hear from the Centers for Medicare & Medicaid Services ont he status of
a proposal to add a genetics specialty to the regulations implementing
the Clinical Laboratory Improvement Act Amendments. In addition, the
Committee will discuss the status of its solicitation of public
comments on the Committee's draft report ``Policy Issues Associated
with Undertaking a Large U.S. Population Cohort Project on Genes,
Environment, and Disease'' (posted at https://www4.od.nih.gov/oba/
sacghs/public_comments.htm).
Issues to be discussed on the second day will include several
presentations intended to provide the Committee with a better
understanding of the impact of gene patents and licensing practices on
access to genetic tests and services as well as deliberations about the
Committee's next steps on this issue. The Committee will also be
updated about the status of Federal genetic non-discrimination
legislation and the work of the two interagency work groups monitoring
claims made by companies advertising genetic tests on the Internet
[[Page 29655]]
and evaluating the public health impact of DTC marketing of genetic
tests.
Time will be provided each day for public comments. The Committee
would welcome hearing from anyone wishing to provide public comment on
any issue related to genetics, health and society. Individuals who
would like to provide public comment should notify the SACGHS Executive
Secretary, Ms. Sarah Carr, by telephone at 301-496-9838 or E-mail at
sc112c@nih.gov. The SACGHS office is located at 6705 Rockledge Drive,
Suite 750, Bethesda, MD 20892. Anyone planning to attend the meeting
who is in need of special assistance, such as sign language
interpretation or other reasonable accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a, section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established SACGHS to serve as a public forum for deliberations on the
broad range of human health and societal issues raised by the
development and use of genetic technologies and, as warranted, to
provide advice on these issues. The draft meeting agenda and other
information about SACGHS, including information about access to the
Webcast, will be available at the following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
Dated: May 15, 2006.
Anna Snouffer,
Acting Director, NIH Office of Federal Advisory Committee Policy.
[FR Doc. 06-4772 Filed 5-22-06; 8:45 am]
BILLING CODE 4140-01-M
